MedPath

Evaluation of risk of glucose fluctuation during nighttime by Average Daily Risk Range (ADRR) in type 1 diabetes

Not Applicable
Conditions
type 1 diabetes
Registration Number
JPRN-UMIN000021172
Lead Sponsor
Juntendo University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with liver cirrhosis and renal failure (hemodialysis and serum creatinine 2.0mg/dl and over) 2) Pregnant patients 3) Malignancy 4) Considered inadequate by the investigator

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Correlations between frequencies of hypoglycemia (below 70mg/dl), hyperglycemia (200mg/dl and over) and mean blood glucose during nighttime (0:00-5:59) and ADRR
Secondary Outcome Measures
NameTimeMethod
Correlations between frequencies of hypoglycemia (below 70mg/dl), hyperglycemia (200mg/dl and over) and mean blood glucose during daytime (6:00-23:59) and ADRR
© Copyright 2025. All Rights Reserved by MedPath